AccuStem Sciences, Inc. (ACUT)

Market Cap	6.04M +71.6%
Revenue (ttm)	n/a
Net Income	-1.61M
EPS	-0.11
Shares Out	16.07M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	350
Average Volume	2,052
Open	0.3757
Previous Close	0.3757
Day's Range	0.3757 - 0.3757
52-Week Range	0.3757 - 2.3300
Beta	2.44
RSI	33.67
Earnings Date	Feb 27, 2026

About AccuStem Sciences

AccuStem Sciences, Inc., a clinical stage diagnostics company, focuses on developing and commercializing a suite of novel genomic tests for oncology care. It offers MSC test, a 24-micro RNA (miRNA) assay designed to help determine whether lung nodules identified by low dose computer tomography screening are benign or malignant. The company also provides StemPrintER, a 20-gene prognostic assay to predict the risk of distant recurrence in luminal breast cancer patients. The company has a partnership with EmeritusDX for the development of non-inva...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2013
• Employees: 2
• Stock Exchange: OTCMKTS
• Ticker Symbol: ACUT